Comparative Evaluation of Rituximab Versus Approved Therapies in Aquaporin-4-IgG-Positive Neuromyelitis Optica Spectrum Disorder: A Systematic Review and Network Meta-analysis

Early Access (Web of Science), Review Article (Web of Science)

• cited authors: Barzegar, Mahdi; Samadzadeh, Sara; Audoin, Bertrand; Berthele, Achim; Altintas, Ayse; Willekens, Barbara; Laakso, Sini; Jahani, Shima; Papp, Viktoria; Zappe, Clarissa; Lefter, Antonia; Siva, Aksel; Afshari-Safavi, Alireza; Moller, Soren; Wokke, Beatrijs; Cortese, Rosa; Illes, Zsolt; Huda, Saif; Paulus, Rommer; Messina, Silvia; Collongues, Nicolas; Ringelstein, Marius; Cobo-Calvo, Alvaro; Hacohen, Yael; Arrambide, Georgina; Palace, Jacqueline; Mariotto, Sara; Marignier, Romain; Geraldes, Ruth; Paul, Friedemann; Asgari, Nasrin
• publication date: July 16, 2026
• webpage: Web of Science
• published in: NEUROLOGY AND THERAPY Journal
• category: CLINICAL NEUROLOGY Category

keywords

• Eculizumab
• Inebilizumab
• Network meta-analysis
• Neuromyelitis optica spectrum disorder
• Randomized controlled trials
• Ravulizumab
• Rituximab
• Satralizumab
• Tocilizumab